 |
Video: Compound Annual Growth Rate (CAGR) Definition
|
 |
| Date |
Open |
High |
Low |
Close |
Volume |
| 09/04/2026 |
$11.37 |
$11.45 |
$11.05 |
$11.08 |
222.50K | | 09/08/2026 |
$11.07 |
$11.07 |
$10.31 |
$10.60 |
915.40K | | 09/09/2026 |
$10.60 |
$10.71 |
$8.85 |
$8.86 |
1.00M | | 09/10/2026 |
$8.75 |
$8.79 |
$8.21 |
$8.24 |
646.70K | | 09/11/2026 |
$8.38 |
$8.49 |
$7.95 |
$8.12 |
2.03M |
 |
| Corbus Pharmaceuticals Holdings, Inc. is a precision oncology company with a diversified portfolio. Co.'s pipeline is comprised of two experimental drugs targeting solid tumors: CRB-701, which is an antibody drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload and CRB-601, which is an anti-integrin monoclonal antibody that blocks the activation of TGF? expressed on cancer cells. Its pipeline also includes CRB-913, which is a highly peripherally restricted cannabinoid type-1 (CB1) receptor inverse agonist for the treatment of obesity. It has in-licensed the intellectual property for CRB-601 from Dr. | |
 |

Corbus Pharmaceuticals Holdings (CRBP) has the following price history information. Looking back at CRBP historical stock prices for the last five trading days, on September 04, 2026, CRBP opened at $11.37, traded as high as $11.45 and as low as $11.05, and closed at $11.08. Trading volume was a total of 222.50K shares. On September 08, 2026, CRBP opened at $11.07, traded as high as $11.07 and as low as $10.31, and closed at $10.60. Trading volume was a total of 915.40K shares. On September 09, 2026, CRBP opened at $10.60, traded as high as $10.71 and as low as $8.85, and closed at $8.86. Trading volume was a total of 1.00M shares. On September 10, 2026, CRBP opened at $8.75, traded as high as $8.79 and as low as $8.21, and closed at $8.24. Trading volume was a total of 646.70K shares. On September 11, 2026, CRBP opened at $8.38, traded as high as $8.49 and as low as $7.95, and closed at $8.12. Trading volume was a total of 2.03M shares.
CRBP Historical Stock Prices By Date:

Below, we examine the compound annual growth rate — CAGR for short — of an investment into Corbus Pharmaceuticals Holdings shares, starting with a $10,000 purchase of CRBP, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
09/14/2016 |
|
| End date: |
09/11/2026 |
|
| Start price/share: |
$194.40 |
|
| End price/share: |
$8.12 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
-95.82% |
|
| Average Annual Total Return: |
-27.21% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$417.92 |
|
| Years: |
10.00 |
|
|
 |
| Date |
Close |
| 09/04/2026 | $11.08 | | 09/08/2026 | $10.60 | | 09/09/2026 | $8.86 | | 09/10/2026 | $8.24 | | 09/11/2026 | $8.12 |
|
 |